The Third Medicine Vigilance Seminar
This is the Japanese Essential-Medicine-List !
All Your Medicines Necessary? Safe?
Organized by : NPO Japan Institute of Pharmacovigilance
and
The Informed Prescriber
Supported by : Medicines san Frontieres Japan
Held on 26(Sat.) Oct〜 27(San.) Oct 2002 at Konohana Kaikan Osaka
Attending 600 participants in total
Main lecture
A. Ellen t'Hoen : Coordinator of the Globalization Project of Medicines san
Frontieres Access to Essential Medicines Campaign
B. David H Banta M.D., M.P.H.
Health Technology Consultant World Health Organization (EURO)
Day 1 : 26 Oct. (Saturday) 10:00〜
１．INTRODUCTION "What are essential medicines ?" (general meeting)
・Introduction to Essential Medicine (drug) concept
(guide of essential medicines presenting some common medicines)
・Point of change in WHO's 12th EML
2. Plenary session (general meeting)
Who is Healthy? How is disease? What is Essential Mediceine?
Looking at cholesterol level, blood pressure and fever
Note the risk of death from all cause:
Beneficial for one thing but not for others; totally how?
・"Don't you mind if you die earlier by lowering cholesterol to prevent heart attack?"
・"Are you all right if you die earlier by lowering blood pressure so strictly to prevent stroke?"
・"Are you all right if you recover later from flu by lowering your body temperature only temporarily?"
Lunch
3. Lecture by guest from abroad (general meeting)
A. Access to medicines should not be a luxury for the rich but a right for all
Ellen t'Hoen : Coordinator of the Globalization Project of Medicines san
Frontieres Access to Essential Medicines Campaign
B. Pharmaceutical coverage policy in Europe Focusing on the Experience of the Netherlands and Switzerland
David H Banta : Health Technology Consultant, WHO(Euro)
4. Essential medicine of some particular groups (section meeting)
A. Essential medicines for Acute diseases or for the improvement of symptoms
(antipyretics, medicines for dyspepsia, for diarrhea or for constipation, medicines for relief of pain)
・ note on the true endpoints
・ considering the effects of medicines on the natural course of these
diseases
B. Essential medicines for Allergic diseases (skin diseases, asthma)
・ make sure what is the true endpoint
・ considering the effects of medicines on the natural course of these
diseases
C. Essential medicines for psychiatric diseases
(especially on sleeping pills, anti-anxiety agents)
・Attention to the dependence, tolerance
Is there any difference one to another?
Can't you sleep without sleeping pills?
What did you try except pills to sleep?
・Newer vs older ones (on antidepressant and/or anti-psychotics)
Day 2 : 27 Oct (Sunday)
6. Current topics and EBM (section meeting)
A. Tricks of the new drug approval
example: anti-cancer drugs
B. Introduction to EBM
・Introduction to EBM
・Importance of endpoint in EBM especially in Japan
・Clinical trial for atopic dermatitis for example
C. DTCA and advertisement of ethical drugs on mass-media in Japan
D. Talk with Ellen t'Hoen and David H Banta
Lunch
7. General meeting
A. What are essential medicines and how are they used in the practices
・Proposal of Japanese Essential medicine list
・How are they used in the current medical practices
a) In community hospitals
b) In general practitioners
・What is the difficulties in practicing only by the medicines in the
Essential medicine list (WHO and/or Japan)
Short break
B. On the generic medicines
・generic vs brand
Is the quality of generic products lower than that of brand products?
How equivalent tests done? How are the price, supply, and information?
a) From the view point of a officer on the quality control
b) From the view point of a manager of a company producing generics
c) Questionnaire survey on the generic products by JIP
(equivalent tests, supply of drugs and information)
C. What are deeded to promote rational use of Japanese essential medicines?
8. Golden pill prize Japan selected by NPOJIP and TIP
9. Closing remarks